ALB and metabolic dysfunction-associated steatotic liver disease: Presently, the major finding is that Alb−/− mice, even when they are obese, exhibit drastic improvements in glucoregulation and hepatic steatosis, and this new knowledge about the regulation of metabolism is directly relevant to the current epidemics of T2D and NAFLD.